Nemaura Medical Inc (NMRD) Return on Investment ROI from the third quarter of 2024 to third quarter of 2023 and for the year 2024, average high and low, overall ranking from Dec 31 2023 to Dec 31 2022 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Nemaura Medical Inc   (NMRD)


Nemaura Medical Inc's ROI from its third quarter of 2024 to the third quarter of 2023 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Nemaura Medical Inc's ROI in the third quarter of 2024?
Due to the stockholders deficit and subsequent negative measured investments, it was not possible to calculate Nemaura Medical Inc 's return on investment (ROI) in its third quarter of 2024

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Dec 31 2023)
III. Quarter		 (Sep 30 2023)
II. Quarter		 (Jun 30 2023)
I. Quarter		 (Mar 31 2023)
IV. Quarter		 (Dec 31 2022)
III. Quarter
Y / Y Investment Change TTM - - - - -76.68 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions -18 -13 -13 -8 0
Return On Investment (TTM) - - - - -
NMRD's Overall Ranking # # # # #
Seq. Investment Change TTM - - - - -38.28 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -11 -10 -13 -14 -13

NMRD Company Profile >> Back to NMRD Roi Comparisons >> See Annual NMRD Return On Investment



Return On Investment NMRD's Ranking
Within: No.
Industry #
Sector #
Overall #

Return On Investment Statistics
High Average Low
0 %
0 %
0 %
 







Financial Statements
Nemaura Medical Inc's III. Quarter Investments $ -18 Millions NMRD's Balance sheet
Nemaura Medical Inc's III. Quarter Income $ -2 Millions Quarterly NMRD's Income Statement
NMRD's Income by Division See NMRD's Income by Division


NMRD Annual Return On Investment (Mar 31 2023)
2023		 (Mar 31 2022)
2022		 (Mar 31 2021)
2021		 (Mar 31 2020)
2020		 (Mar 31 2019)
2019
Total Investments in Millions -8 2 29 0 3
Y / Y Investment Growth - -94.73 % - - -36.36 %
Net Income in Millions -14 -14 -6 -4 -4
Y / Y Net Income Growth - - - - -
Annual Return On Investment - -914.17 % -21.71 % - -128.52 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Medical Equipment & Supplies Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
NMRD's Roi Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for NMRD's Competitors
Subscribers only: Roi for Nemaura Medical Inc's Suppliers
Subscribers only: Return On Investment for NMRD's Customers

Other Ratios
NMRD's Roa NMRD's Inventory Turnover Ratio NMRD's Growth Rates NMRD's Dividend Statistics
NMRD's Profitability Ratios NMRD's Asset Turnover Ratio NMRD's Dividend Growth
NMRD's Roe NMRD's Valuation Ratios NMRD's Financial Strength Ratios NMRD's Dividend Payout Ratio



Companies with similar Return On Investment at Dec 31 2023, within Healthcare Sector ROI
Glucotrack Inc   164.38 %
Roivant Sciences Ltd   119.08 %
Icecure Medical Ltd  113.45 %
Entera Bio Ltd   99.03 %
Ladrx Corporation  92.24 %
Profound Medical Corp   76.09 %
Cv Sciences Inc   76.03 %
Galmed Pharmaceuticals Ltd   74.21 %
Scynexis Inc   65.85 %
Dariohealth Corp   62.29 %
Cardiff Lexington Corporation  55.55 %
Biomx Inc  51.59 %
Procaps Group S a   50.81 %
Voyager Therapeutics Inc   47.85 %
Enzo Biochem Inc  47.58 %
Mimedx Group Inc   45.14 %
Siga Technologies Inc  43.86 %
Scinai Immunotherapeutics Ltd  43.64 %
Idexx Laboratories Inc  40.73 %
Star Equity Holdings Inc   40.08 %
Elite Pharmaceuticals Inc   39.87 %
Medpace Holdings Inc   37.64 %
Mettler toledo International Inc   34.44 %
Nrc Health  33.18 %
Semler Scientific inc   30.60 %
Alpha Tau Medical Ltd  28.76 %
Escalon Medical Corp   27.28 %
Johnson and Johnson  26.63 %
Lantheus Holdings Inc   25.80 %
Inmode Ltd   24.77 %

Date modified: 2026-09-08T15:11:09+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.